These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29260029)

  • 41. Clinical study of central cholinergic pathway damage in two mild cognitive impairment patients.
    Liu Q; Zhong M; Yuan S; Niu C; Ma X
    Neurol Sci; 2021 Nov; 42(11):4707-4717. PubMed ID: 34528182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive performance in community-dwelling older adults with stroke and the contribution of age and diffuse subcortical damage: a population-based study in rural Ecuador (The Atahualpa Project).
    Del Brutto OH; Mera RM; Zambrano M; Lama J
    Aging Clin Exp Res; 2015 Oct; 27(5):647-52. PubMed ID: 25724660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive impact of lacunar infarcts and white matter hyperintensity volume.
    Warren MW; Weiner MF; Rossetti HC; McColl R; Peshock R; King KS
    Dement Geriatr Cogn Dis Extra; 2015; 5(1):170-5. PubMed ID: 26034488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of regional white matter lesions on cognitive function in subcortical vascular cognitive impairment.
    Ai Q; Pu YH; Sy C; Liu LP; Gao PY
    Neurol Res; 2014 May; 36(5):434-43. PubMed ID: 24641691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.
    Tran P; Thoprakarn U; Gourieux E; Dos Santos CL; Cavedo E; Guizard N; Cotton F; Krolak-Salmon P; Delmaire C; Heidelberg D; Pyatigorskaya N; Ströer S; Dormont D; Martini JB; Chupin M;
    Neuroimage Clin; 2022; 33():102940. PubMed ID: 35051744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Additional Contribution of White Matter Hyperintensity Location to Post-stroke Cognitive Impairment: Insights From a Multiple-Lesion Symptom Mapping Study.
    Zhao L; Wong A; Luo Y; Liu W; Chu WWC; Abrigo JM; Lee RKL; Mok V; Shi L
    Front Neurosci; 2018; 12():290. PubMed ID: 29765301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the R
    Washida K; Kowa H; Hamaguchi H; Kanda F; Toda T
    Intern Med; 2017 Oct; 56(20):2719-2725. PubMed ID: 28924104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe Lesions Involving Cortical Cholinergic Pathways Predict Poorer Functional Outcome in Acute Ischemic Stroke.
    Qu JF; Chen YK; Luo GP; Zhao JH; Zhong HH; Yin HP
    Stroke; 2018 Dec; 49(12):2983-2989. PubMed ID: 30571427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. White matter hyperintensities and cognitive impairment during electroconvulsive therapy in severely depressed elderly patients.
    Oudega ML; van Exel E; Wattjes MP; Comijs HC; Scheltens P; Barkhof F; Eikelenboom P; de Craen AJ; Beekman AT; Stek ML
    Am J Geriatr Psychiatry; 2014 Feb; 22(2):157-66. PubMed ID: 23567440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia.
    Altamura C; Scrascia F; Quattrocchi CC; Errante Y; Gangemi E; Curcio G; Ursini F; Silvestrini M; Maggio P; Beomonte Zobel B; Rossini PM; Pasqualetti P; Falsetti L; Vernieri F
    J Clin Neurol; 2016 Apr; 12(2):201-8. PubMed ID: 27074295
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlations between MRI white matter lesion location and executive function and episodic memory.
    Smith EE; Salat DH; Jeng J; McCreary CR; Fischl B; Schmahmann JD; Dickerson BC; Viswanathan A; Albert MS; Blacker D; Greenberg SM
    Neurology; 2011 Apr; 76(17):1492-9. PubMed ID: 21518999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in the association between white matter hyperintensities and gait performance among older adults with and without cognitive impairment.
    Sakurai R; Inagaki H; Tokumaru AM; Sakurai K; Shimoji K; Kobayashi-Cuya KE; Kitamura A; Watanabe Y; Shinkai S; Awata S;
    Geriatr Gerontol Int; 2021 Mar; 21(3):313-320. PubMed ID: 33494119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment.
    Eguchi A; Kimura N; Aso Y; Yabuuchi K; Ishibashi M; Hori D; Sasaki Y; Nakamichi A; Uesugi S; Jikumaru M; Sumi K; Shimomura T; Matsubara E
    Curr Alzheimer Res; 2019; 16(9):852-860. PubMed ID: 31385770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
    Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
    AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.
    Watson C; Busovaca E; Foley JM; Allen IE; Schwarz CG; Jahanshad N; Nir TM; Esmaeili-Firidouni P; Milanini B; Rosen H; Carmichael OT; Thompson PM; Valcour VG
    J Neurovirol; 2017 Jun; 23(3):422-429. PubMed ID: 28101804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.
    Nazem S; Siderowf AD; Duda JE; Have TT; Colcher A; Horn SS; Moberg PJ; Wilkinson JR; Hurtig HI; Stern MB; Weintraub D
    J Am Geriatr Soc; 2009 Feb; 57(2):304-8. PubMed ID: 19170786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Cognitive Assessment Following Acute Stroke: Feasibility and Comparison between Mini-Mental State Examination and Montreal Cognitive Assessment.
    Suda S; Muraga K; Ishiwata A; Nishimura T; Aoki J; Kanamaru T; Suzuki K; Sakamoto Y; Katano T; Nagai K; Hatake S; Satoi S; Matsumoto N; Nito C; Nishiyama Y; Mishina M; Kimura K
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104688. PubMed ID: 32063455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.